Home |About Us | Meet the Team
Company History
Caristo Diagnostics
Founded in 2018

Caristo was founded in 2018 by Cardiologists at the University of Oxford, following a decade of scientific research and technical development, to revolutionise diagnosis and treatment. With Care as one of our core values, we are committed to our mission of transforming health outcomes through clinical and scientific innovation.
Our first “game-changing” technology provides unique insights into coronary artery inflammation.
While we have known for over 50 years that heart attacks are caused by inflammation in coronary arteries (which supply blood to the heart), physicians have been unable to visualize and measure coronary inflammation with routine cardiac tests.

It is now possible to extract this information from any clinical CT heart scan with Caristo’s technology (known as CaRi-Heart®), allowing physicians to prescribe effective, personalised treatments with our more comprehensive risk assessment tool.

CaRi-Heart® received CE mark, under the new MDR process, in February 2021 and is commercially available in Europe.

New products in the pipeline will also be capable of predicting stroke and diabetes risk, years in advance.
Meet the Team at Caristo
Co-founder and Chief Executive Officer
Dr. Cheerag Shirodaria
MBBS MD MBA FRCP Has been involved in cardiovascular research for more than 25 years. Was General Manager for Medical Devices & Diagnostics and Cardiovascular Therapeutic Area Head at Covance. Is an Honorary Consultant Cardiologist at Oxford University Hospitals NHS Foundation Trust.
Co-founder and Chief Scientific Officer
Prof. Charalambos Antoniades
MD PhD FESC Pioneered the research on the relationship between adipose tissue and the cardiovascular system, with specific interest in non-invasive imaging of inflammation. This knowledge has been applied in a variety of diseases, ranging from cardiovascular disease to COVID-19. Deputy Head of the Division of Cardiovascular Medicine at the University of Oxford, and Chair of the British Atherosclerosis Society.
Co-founder and Chief Translational Officer
Prof. Stefan Neubauer
MD FRCP FACC FMedSci FSCMR Devoted his work to the development and application of novel imaging techniques in MRI and spectroscopy, and most recently in coronary CT. Head of the Division of Cardiovascular Medicine and Director of the Oxford Centre for Clinical Magnetic Resonance Research (OCMR) at the University of Oxford and Past President of the Society for Cardiovascular Magnetic Resonance (SCMR).
Co-founder and Chief Medical Officer
Prof. Keith Channon
Clinical interventional cardiologist and highly experienced research leader in cardiometabolic disease and risk. Professor at the University of Oxford, with expertise in healthcare innovations in the NHS through NIHR and Director of Academic Health Science Centre.
Chief Operating Officer
Dr Dan Green
MSci PhD Over 20 years' experience in medical imaging and devices, both software and hardware. Responsible for the day-to-day operation of the company, including finance and the management and delivery of Caristo's analysis services.
Chief Technical Officer
Dr David Schottlander
PhD Over 20 years' product and technology leadership in software and hardware medical devices in companies from start-up to multi-national. Has led commercialisation of multiple novel clinical applications and healthcare platforms (e.g. PET Myocardial Bloodflow, teamplay digital ecosystem), as well as leading device redesign to drive company growth and scale-up.
General Counsel
Tamsin Crane
PhD Corporate and commercial solicitor with extensive experience advising emerging and established companies on commercial contracts, protection of intellectual property rights, regulatory and corporate governance matters, strategic relationships and financings
Chief Commercial Officer
Serge Bellon
Over 30 years of experience in medical imaging and devices, mostly in the cardiovascular field, including assignments in Japan and the USA. Held marketing, sales and general management positions in start-up and multinational companies.
Head of Quality and Regulatory
James Davis
Over 20 years experience working with medical devices at large multinational companies as well as startup and SMEs. Responsible for regulatory compliance and quality management, has set up a combined management system compliant to ISO 9001, 13485 and 27001 requirements.